Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 285

1.

Direct Assessment of Health Utilities Using the Standard Gamble Among Patients With Primary Intracerebral Hemorrhage.

Slaughter KB, Meyer EG, Bambhroliya AB, Meeks JR, Ahmed W, Bowry R, Behrouz R, Mir O, Begley C, Tyson JE, Miller C, Warach S, Grotta JC, McCullough LD, Savitz SI, Vahidy FS.

Circ Cardiovasc Qual Outcomes. 2019 Sep;12(9):e005606. doi: 10.1161/CIRCOUTCOMES.119.005606. Epub 2019 Sep 13.

PMID:
31514521
2.

Interneuron Functional Diversity in the Mouse Accessory Olfactory Bulb.

Maksimova MA, Cansler HL, Zuk KE, Torres JM, Roberts DJ, Meeks JP.

eNeuro. 2019 Aug 13;6(4). pii: ENEURO.0058-19.2019. doi: 10.1523/ENEURO.0058-19.2019. Print 2019 Jul/Aug.

3.

Complete Genomes of Symbiotic Cyanobacteria Clarify the Evolution of Vanadium-Nitrogenase.

Nelson JM, Hauser DA, Gudiño JA, Guadalupe YA, Meeks JC, Salazar Allen N, Villarreal JC, Li FW.

Genome Biol Evol. 2019 Jul 1;11(7):1959-1964. doi: 10.1093/gbe/evz137.

4.

Tumor Location May Predict Adverse Pathology and Survival Following Definitive Treatment for Bladder Cancer: A National Cohort Study.

Weiner AB, Desai AS, Meeks JJ.

Eur Urol Oncol. 2019 May;2(3):304-310. doi: 10.1016/j.euo.2018.08.018. Epub 2018 Sep 14.

PMID:
31200845
5.

Limited Upstaging in Luminal Subtype Tumors: Ready for Clinical Practice?

Meeks JJ, McConkey DJ.

Eur Urol. 2019 Aug;76(2):207-208. doi: 10.1016/j.eururo.2019.05.025. Epub 2019 May 31. No abstract available.

PMID:
31155339
6.

Can post-neoadjuvant therapy molecular classification guide future treatment selection for muscle-invasive bladder cancer?

VanderWeele DJ, Meeks JJ, Hussain M.

Transl Androl Urol. 2019 Mar;8(Suppl 1):S91-S92. doi: 10.21037/tau.2018.12.07. No abstract available.

7.

Diagnosis and Treatment of Early Stage Testicular Cancer: AUA Guideline.

Stephenson A, Eggener SE, Bass EB, Chelnick DM, Daneshmand S, Feldman D, Gilligan T, Karam JA, Leibovich B, Liauw SL, Masterson TA, Meeks JJ, Pierorazio PM, Sharma R, Sheinfeld J.

J Urol. 2019 Aug;202(2):272-281. doi: 10.1097/JU.0000000000000318. Epub 2019 Jul 8.

PMID:
31059667
8.

Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors.

Glaser AP, Procissi D, Yu Y, Meeks JJ.

J Vis Exp. 2019 Mar 29;(145). doi: 10.3791/59101.

PMID:
30985757
9.

The Cancer Genome Atlas Expression Subtypes Stratify Response to Checkpoint Inhibition in Advanced Urothelial Cancer and Identify a Subset of Patients with High Survival Probability.

Kim J, Kwiatkowski D, McConkey DJ, Meeks JJ, Freeman SS, Bellmunt J, Getz G, Lerner SP.

Eur Urol. 2019 Jun;75(6):961-964. doi: 10.1016/j.eururo.2019.02.017. Epub 2019 Mar 7.

PMID:
30851984
10.

High in-hospital blood pressure variability and severe disability or death in primary intracerebral hemorrhage patients.

Meeks JR, Bambhroliya AB, Meyer EG, Slaughter KB, Fraher CJ, Sharrief AZ, Bowry R, Ahmed WO, Tyson JE, Miller CC, Warach S, Khan BA, McCullough LD, Savitz SI, Vahidy FS.

Int J Stroke. 2019 Jan 25:1747493019827763. doi: 10.1177/1747493019827763. [Epub ahead of print]

PMID:
30681042
11.

Disparities in the diagnostic evaluation of microhematuriaand implications for the detection of urologic malignancy.

Matulewicz RS, Demzik AL, DeLancey JO, Popescu O, Makarov DV, Meeks JJ.

Urol Oncol. 2019 May;37(5):300.e1-300.e7. doi: 10.1016/j.urolonc.2019.01.007. Epub 2019 Jan 18.

PMID:
30661870
12.

Automated Extraction of Grade, Stage, and Quality Information From Transurethral Resection of Bladder Tumor Pathology Reports Using Natural Language Processing.

Glaser AP, Jordan BJ, Cohen J, Desai A, Silberman P, Meeks JJ.

JCO Clin Cancer Inform. 2018 Dec;2:1-8. doi: 10.1200/CCI.17.00128.

13.

Contemporary Comparison of Open to Robotic Prostatectomy at a Veteran's Affairs Hospital.

Desai A, Hudnall M, Weiner AB, Patel M, Cohen J, Gogana P, Sharifi R, Meeks JJ.

Mil Med. 2019 May 1;184(5-6):e330-e337. doi: 10.1093/milmed/usy352.

PMID:
30535336
14.

Frequency of Testing for Prostate Cancer Using Prostate-Specific Antigen Among Older Men in a Large Health System.

Rowe TA, Lee JY, Meeks JJ, Persell SD.

Jt Comm J Qual Patient Saf. 2019 May;45(5):368-369. doi: 10.1016/j.jcjq.2018.10.003. Epub 2018 Nov 17. No abstract available.

PMID:
30455098
15.

Molecular footprints of muscle-invasive bladder cancer in smoking and nonsmoking patients.

Fantini D, Seiler R, Meeks JJ.

Urol Oncol. 2018 Nov 13. pii: S1078-1439(18)30381-8. doi: 10.1016/j.urolonc.2018.09.017. [Epub ahead of print] Review.

PMID:
30446446
16.

Genomic classification and risk stratification of bladder cancer.

Fantini D, Meeks JJ.

World J Urol. 2019 Sep;37(9):1751-1757. doi: 10.1007/s00345-018-2558-2. Epub 2018 Nov 12.

PMID:
30421072
17.

Changes in Lean Muscle Mass Associated with Neoadjuvant Platinum-Based Chemotherapy in Patients with Muscle Invasive Bladder Cancer.

Rimar KJ, Glaser AP, Kundu S, Schaeffer EM, Meeks J, Psutka SP.

Bladder Cancer. 2018 Oct 29;4(4):411-418. doi: 10.3233/BLC-180188.

18.

T1 bladder cancer: current considerations for diagnosis and management.

Jordan B, Meeks JJ.

Nat Rev Urol. 2019 Jan;16(1):23-34. doi: 10.1038/s41585-018-0105-y. Review.

PMID:
30323201
19.

NCCN Guidelines Insights: Bladder Cancer, Version 5.2018.

Flaig TW, Spiess PE, Agarwal N, Bangs R, Boorjian SA, Buyyounouski MK, Downs TM, Efstathiou JA, Friedlander T, Greenberg RE, Guru KA, Hahn N, Herr HW, Hoimes C, Inman BA, Jimbo M, Kader AK, Lele SM, Meeks JJ, Michalski J, Montgomery JS, Pagliaro LC, Pal SK, Patterson A, Petrylak DP, Plimack ER, Pohar KS, Porter MP, Preston MA, Sexton WJ, Siefker-Radtke AO, Tward J, Wile G, Johnson-Chilla A, Dwyer MA, Gurski LA.

J Natl Compr Canc Netw. 2018 Sep;16(9):1041-1053. doi: 10.6004/jnccn.2018.0072.

PMID:
30181416
20.

Development of a translational medicine protocol for an NCTN genitourinary clinical trial: Critical steps, common pitfalls and a basic guide to translational clinical research.

Meeks JJ, Goldkorn A, Aparicio AM, McConkey DJ.

Urol Oncol. 2019 May;37(5):313-317. doi: 10.1016/j.urolonc.2018.06.008. Epub 2018 Aug 13. Review.

PMID:
30115512
21.

Sensory Adaptation to Chemical Cues by Vomeronasal Sensory Neurons.

Wong WM, Nagel M, Hernandez-Clavijo A, Pifferi S, Menini A, Spehr M, Meeks JP.

eNeuro. 2018 Aug 13;5(4). pii: ENEURO.0223-18.2018. doi: 10.1523/ENEURO.0223-18.2018. eCollection 2018 Jul-Aug.

22.

The BBN model: a mouse bladder cancer model featuring basal-subtype gene expression and MLL3/MLL4 genetic disruption.

Fantini D, Meeks JJ.

Oncoscience. 2018 Jun 29;5(5-6):172-173. doi: 10.18632/oncoscience.439. eCollection 2018 May. No abstract available.

23.

Large-scale forward genetics screening identifies Trpa1 as a chemosensor for predator odor-evoked innate fear behaviors.

Wang Y, Cao L, Lee CY, Matsuo T, Wu K, Asher G, Tang L, Saitoh T, Russell J, Klewe-Nebenius D, Wang L, Soya S, Hasegawa E, Chérasse Y, Zhou J, Li Y, Wang T, Zhan X, Miyoshi C, Irukayama Y, Cao J, Meeks JP, Gautron L, Wang Z, Sakurai K, Funato H, Sakurai T, Yanagisawa M, Nagase H, Kobayakawa R, Kobayakawa K, Beutler B, Liu Q.

Nat Commun. 2018 May 23;9(1):2041. doi: 10.1038/s41467-018-04324-3.

24.

Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy.

Wang L, Zhao Z, Ozark PA, Fantini D, Marshall SA, Rendleman EJ, Cozzolino KA, Louis N, He X, Morgan MA, Takahashi YH, Collings CK, Smith ER, Ntziachristos P, Savas JN, Zou L, Hashizume R, Meeks JJ, Shilatifard A.

Nat Med. 2018 Jun;24(6):758-769. doi: 10.1038/s41591-018-0034-6. Epub 2018 May 21.

25.

Transversus Abdominis Plane Blockade as Part of a Multimodal Postoperative Analgesia Plan in Patients Undergoing Radical Cystectomy.

Matulewicz RS, Patel M, Jordan BJ, Morano J, Frainey B, Bhanji Y, Bux M, Nader A, Kundu SD, Meeks JJ.

Bladder Cancer. 2018 Apr 26;4(2):161-167. doi: 10.3233/BLC-170157.

26.

Editorial Comment.

Meeks JJ, Glaser AP.

J Urol. 2018 Jul;200(1):60. doi: 10.1016/j.juro.2017.11.157. Epub 2018 Apr 19. No abstract available.

PMID:
29679580
27.

Rates and Predictors of Conversion to Open Surgery During Minimally Invasive Radical Cystectomy.

Ko OS, Weiner AB, Smith ND, Meeks JJ.

J Endourol. 2018 Jun;32(6):488-494. doi: 10.1089/end.2018.0079. Epub 2018 Apr 5.

PMID:
29620960
28.

Rationale and Design of a Statewide Cohort to examine efficient resource utilization for patients with Intracerebral hemorrhage (EnRICH).

Vahidy FS, Meyer EG, Bambhroliya AB, Meeks JR, Begley CE, Wu TC, Tyson JE, Miller CC, Bowry R, Ahmed WO, Gealogo GA, McCullough LD, Warach S, Savitz SI.

BMC Neurol. 2018 Mar 21;18(1):31. doi: 10.1186/s12883-018-1036-1.

29.

Robotic-Assisted vs Laparoscopic Radical Nephrectomy.

Weiner AB, Matulewicz RS, Meeks JJ.

JAMA. 2018 Mar 20;319(11):1165. doi: 10.1001/jama.2017.21848. No abstract available.

PMID:
29558547
30.

Excreted Steroids in Vertebrate Social Communication.

Doyle WI, Meeks JP.

J Neurosci. 2018 Apr 4;38(14):3377-3387. doi: 10.1523/JNEUROSCI.2488-17.2018. Epub 2018 Mar 8.

31.

Physician Perceptions of Patient Health: A Comparative Analysis between Urologist and Hospitalist Perceptions of Need for Inpatient Hospitalist Comanagement Following Radical Cystectomy.

Hannick JH, Adams W, Sandhu J, Kliethermes S, Mazur DJ, Meeks JJ, Sobek S, Coogan CL, Sadaf A, Quek ML, Schulwolf E.

Curr Urol. 2017 Nov;11(1):9-15. doi: 10.1159/000447188. Epub 2017 Nov 30.

32.

APOBEC-mediated mutagenesis in urothelial carcinoma is associated with improved survival, mutations in DNA damage response genes, and immune response.

Glaser AP, Fantini D, Wang Y, Yu Y, Rimar KJ, Podojil JR, Miller SD, Meeks JJ.

Oncotarget. 2017 Dec 16;9(4):4537-4548. doi: 10.18632/oncotarget.23344. eCollection 2018 Jan 12.

33.

Clinical Outcome of Retroperitoneal Lymph Node Dissection after Chemotherapy in Patients with Pure Embryonal Carcinoma in the Orchiectomy Specimen.

Dowling CM, Assel M, Musser JE, Meeks JJ, Sjoberg DD, Bosl G, Motzer R, Bajorin D, Feldman D, Carver BS, Sheinfeld J.

Urology. 2018 Apr;114:133-138. doi: 10.1016/j.urology.2018.01.014. Epub 2018 Feb 2.

PMID:
29410311
34.

A Carcinogen-induced mouse model recapitulates the molecular alterations of human muscle invasive bladder cancer.

Fantini D, Glaser AP, Rimar KJ, Wang Y, Schipma M, Varghese N, Rademaker A, Behdad A, Yellapa A, Yu Y, Sze CC, Wang L, Zhao Z, Crawford SE, Hu D, Licht JD, Collings CK, Bartom E, Theodorescu D, Shilatifard A, Meeks JJ.

Oncogene. 2018 Apr;37(14):1911-1925. doi: 10.1038/s41388-017-0099-6. Epub 2018 Jan 25.

35.

Discrepancies in staging, treatment, and delays to treatment may explain disparities in bladder cancer outcomes: An update from the National Cancer Data Base (2004-2013).

Weiner AB, Keeter MK, Manjunath A, Meeks JJ.

Urol Oncol. 2018 May;36(5):237.e9-237.e17. doi: 10.1016/j.urolonc.2017.12.015. Epub 2018 Jan 12.

PMID:
29338913
36.

Correction: Odorant Responses and Courtship Behaviors Influenced by at4 Neurons in Drosophila.

Pitts S, Pelser E, Meeks J, Smith D.

PLoS One. 2018 Jan 2;13(1):e0190805. doi: 10.1371/journal.pone.0190805. eCollection 2018.

37.

Molecular Landscape of Non-Muscle Invasive Bladder Cancer.

Meeks JJ, Lerner SP.

Cancer Cell. 2017 Nov 13;32(5):550-551. doi: 10.1016/j.ccell.2017.08.015.

38.

Bladder Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology.

Spiess PE, Agarwal N, Bangs R, Boorjian SA, Buyyounouski MK, Clark PE, Downs TM, Efstathiou JA, Flaig TW, Friedlander T, Greenberg RE, Guru KA, Hahn N, Herr HW, Hoimes C, Inman BA, Jimbo M, Kader AK, Lele SM, Meeks JJ, Michalski J, Montgomery JS, Pagliaro LC, Pal SK, Patterson A, Plimack ER, Pohar KS, Porter MP, Preston MA, Sexton WJ, Siefker-Radtke AO, Sonpavde G, Tward J, Wile G, Dwyer MA, Gurski LA.

J Natl Compr Canc Netw. 2017 Oct;15(10):1240-1267. doi: 10.6004/jnccn.2017.0156.

PMID:
28982750
39.

Reply by the Authors.

Oberlin DT, Catalona WJ, Meeks JJ.

Urology. 2017 Dec;110:267-268. doi: 10.1016/j.urology.2017.08.023. Epub 2017 Aug 25. No abstract available.

40.

Treatment of Nonmetastatic Muscle-Invasive Bladder Cancer: American Urological Association/American Society of Clinical Oncology/American Society for Radiation Oncology/Society of Urologic Oncology Clinical Practice Guideline Summary.

Chang SS, Bochner BH, Chou R, Dreicer R, Kamat AM, Lerner SP, Lotan Y, Meeks JJ, Michalski JM, Morgan TM, Quale DZ, Rosenberg JE, Zietman AL, Holzbeierlein JM.

J Oncol Pract. 2017 Sep;13(9):621-625. doi: 10.1200/JOP.2017.024919. Epub 2017 Aug 10. No abstract available.

PMID:
28796558
41.

Experience-Dependent Plasticity in Accessory Olfactory Bulb Interneurons following Male-Male Social Interaction.

Cansler HL, Maksimova MA, Meeks JP.

J Neurosci. 2017 Jul 26;37(30):7240-7252. doi: 10.1523/JNEUROSCI.1031-17.2017. Epub 2017 Jun 28.

42.

Editorial Comment.

Matulewicz RS, Meeks JJ.

J Urol. 2017 Sep;198(3):519. doi: 10.1016/j.juro.2017.01.120. Epub 2017 May 30. No abstract available.

PMID:
28576555
43.

Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline.

Chang SS, Bochner BH, Chou R, Dreicer R, Kamat AM, Lerner SP, Lotan Y, Meeks JJ, Michalski JM, Morgan TM, Quale DZ, Rosenberg JE, Zietman AL, Holzbeierlein JM.

J Urol. 2017 Sep;198(3):552-559. doi: 10.1016/j.juro.2017.04.086. Epub 2017 Apr 26. Erratum in: J Urol. 2017 Nov;198(5):1175.

44.

Cystoscopy.

Matulewicz RS, DeLancey JO, Meeks JJ.

JAMA. 2017 Mar 21;317(11):1187. doi: 10.1001/jama.2017.0364. No abstract available.

PMID:
28324094
45.

The emerging role of homologous recombination repair and PARP inhibitors in genitourinary malignancies.

Rimar KJ, Tran PT, Matulewicz RS, Hussain M, Meeks JJ.

Cancer. 2017 Jun 1;123(11):1912-1924. doi: 10.1002/cncr.30631. Epub 2017 Mar 21. Review.

46.

Robot-assisted retroperitoneal lymph node dissection (RA-RPLND) in the adolescent population.

Glaser AP, Bowen DK, Lindgren BW, Meeks JJ.

J Pediatr Urol. 2017 Apr;13(2):223-224. doi: 10.1016/j.jpurol.2017.01.007. Epub 2017 Feb 17.

PMID:
28262537
47.

The evolving genomic landscape of urothelial carcinoma.

Glaser AP, Fantini D, Shilatifard A, Schaeffer EM, Meeks JJ.

Nat Rev Urol. 2017 Feb 7;14(4):215-229. doi: 10.1038/nrurol.2017.11. [Epub ahead of print] Review.

PMID:
28169993
48.

Dipstick Urinalysis as a Test for Microhematuria and Occult Bladder Cancer.

Matulewicz RS, DeLancey JO, Pavey E, Schaeffer EM, Popescu O, Meeks JJ.

Bladder Cancer. 2017 Jan 27;3(1):45-49. doi: 10.3233/BLC-160068.

49.

Heterogeneous effects of norepinephrine on spontaneous and stimulus-driven activity in the male accessory olfactory bulb.

Doyle WI, Meeks JP.

J Neurophysiol. 2017 Mar 1;117(3):1342-1351. doi: 10.1152/jn.00871.2016. Epub 2017 Jan 4.

50.

Bacillus Calmette-Guérin Manufacturing and SWOG S1602 Intergroup Clinical Trial.

Meeks JJ, Lerner SP, Svatek RS.

J Urol. 2017 Mar;197(3 Pt 1):538-540. doi: 10.1016/j.juro.2016.12.024. Epub 2016 Dec 16. No abstract available.

PMID:
27992750

Supplemental Content

Support Center